QCM : Fundamentals of Infectious Disease and Antibiotics — 10 questions

Questions et réponses du QCM

1. What is an infectious disease?

An illness caused by a pathogen such as bacteria, viruses, fungi, or parasites.
Any illness that can be prevented by vaccination.
A disease that is transmitted only through contact with contaminated surfaces.
A genetic disorder passed from parent to child.

An illness caused by a pathogen such as bacteria, viruses, fungi, or parasites.

Explication

An infectious disease is defined as an illness caused by pathogens such as viruses, bacteria, fungi, protozoa, parasites, or infectious proteins (prions). The other options describe different concepts: transmission methods, vaccine-preventable diseases, or genetic conditions, which are not the definitions of infectious diseases.

2. Which disease is primarily transmitted via airborne droplets?

Hepatitis A
MRSA
Malaria
Tuberculosis

Tuberculosis

Explication

Tuberculosis is primarily transmitted through airborne droplets expelled when an infected person coughs or sneezes. The other options are transmitted through different mechanisms: malaria via vectors (mosquitoes), hepatitis A via fecal-oral route, and MRSA mainly through contact.

3. What is the primary role or purpose of different antibiotic drug classes?

To stimulate the host immune response directly
To neutralize bacterial toxins without affecting bacteria
To inhibit or kill bacteria by targeting specific bacterial processes
To enhance bacterial growth for research purposes

To inhibit or kill bacteria by targeting specific bacterial processes

Explication

The main purpose of antibiotic drug classes is to target specific bacterial processes, such as cell wall synthesis or protein synthesis, to inhibit bacterial growth or kill bacteria, thereby treating infections effectively.

4. Which of the following events related to empiric antibiotic therapy was established first in history?

The development of antibiotic susceptibility testing techniques
The implementation of antimicrobial stewardship programs in hospitals
The publication of the first clinical guidelines for empiric therapy
The discovery of penicillin and the beginning of antibiotic use in the 1940s

The discovery of penicillin and the beginning of antibiotic use in the 1940s

Explication

The discovery of penicillin in 1928 and its subsequent development and widespread use in the 1940s marked the beginning of antibiotic use in medicine. This event predates the development of formal clinical guidelines and stewardship programs, making it the earliest milestone in the history of empiric antibiotic therapy.

5. How do enzymatic degradation mechanisms of antibiotic resistance differ from target modification mechanisms?

Both mechanisms involve bacteria producing enzymes that destroy antibiotics, but enzymatic degradation is specific to beta-lactamases, whereas target modification involves altering bacterial DNA.
Enzymatic degradation changes the bacterial cell wall to prevent antibiotic entry, while target modification involves producing enzymes that destroy antibiotics.
Enzymatic degradation involves bacteria producing enzymes that chemically break down antibiotics, whereas target modification involves structural changes in bacterial components to prevent antibiotic binding.
Enzymatic degradation and target modification are essentially the same process, both involving bacteria changing their genetic makeup to resist antibiotics.

Enzymatic degradation involves bacteria producing enzymes that chemically break down antibiotics, whereas target modification involves structural changes in bacterial components to prevent antibiotic binding.

Explication

Enzymatic degradation involves bacteria producing enzymes, such as beta-lactamases, that chemically break down antibiotics, while target modification involves structural changes in bacterial components, such as penicillin-binding proteins, to prevent antibiotics from binding effectively. These are distinct resistance mechanisms.

6. Who is credited with discovering beta-lactamases, enzymes that confer bacterial resistance to beta-lactam antibiotics?

Har Gobind Khorana
Abraham and Chain
Gerhard L. Luria
Alexander Fleming

Abraham and Chain

Explication

Abraham and Chain are credited with discovering beta-lactamases in 1940, which are enzymes that bacteria produce to confer resistance to beta-lactam antibiotics, such as penicillins and cephalosporins.

7. What is a potential consequence of using broad-spectrum antibiotics instead of narrow-spectrum agents in clinical practice?

Increased risk of antibiotic resistance development
Less disruption of normal flora
Reduced efficacy against specific pathogens
Decreased likelihood of adverse effects

Increased risk of antibiotic resistance development

Explication

Using broad-spectrum antibiotics can lead to increased antibiotic resistance because they exert selection pressure on a wide range of bacteria, promoting the emergence of resistant strains. Narrow-spectrum agents are preferred when possible to minimize this risk.

8. In managing a patient with a deep tissue infection and renal impairment, how should pharmacokinetic principles influence antibiotic selection and dosing?

Use an antibiotic primarily eliminated hepatically, with no dose adjustment for renal impairment
Select an antibiotic with poor tissue penetration to minimize systemic exposure, with no dose adjustment needed
Choose an antibiotic with high tissue penetration and renal clearance, adjusting dose for renal impairment
Administer a high dose of antibiotics with renal clearance to overcome tissue barriers

Choose an antibiotic with high tissue penetration and renal clearance, adjusting dose for renal impairment

Explication

The correct approach is to select an antibiotic with good tissue penetration suitable for the infection site and adjust the dose based on renal clearance, especially in renal impairment. This ensures effective drug levels at the infection site while preventing toxicity. The other options are incorrect because they either ignore the importance of tissue penetration, do not consider renal function, or recommend inappropriate dosing strategies for renal impairment.

9. Which of the following is a key component of antibiotic monitoring?

Infection site visualization
Patient symptom assessment
Pharmacokinetic modeling
Susceptibility testing and MIC measurement

Susceptibility testing and MIC measurement

Explication

Susceptibility testing and MIC measurement are essential components of antibiotic monitoring because they provide laboratory data on how bacteria respond to antibiotics, guiding therapy adjustments and detecting resistance.

10. What is an antibiogram?

A chart summarizing antimicrobial susceptibility data from bacterial isolates
A laboratory test to identify bacterial pathogens from clinical samples
A method to determine the minimum inhibitory concentration of antibiotics
A process of selecting empiric antibiotics based on local resistance patterns

A chart summarizing antimicrobial susceptibility data from bacterial isolates

Explication

An antibiogram is a chart that summarizes antimicrobial susceptibility data from bacterial isolates over a specific period, guiding empiric antibiotic selection based on local resistance patterns.

Révisez avec les flashcards

Mémorisez les réponses avec 20 flashcards sur Fundamentals of Infectious Disease and Antibiotics.

Infectious Disease — definition?

Illness caused by pathogens like viruses or bacteria.

Pathogen — role?

Microorganism causing disease in hosts.

Transmission — mechanisms?

Contact, ingestion, droplets, vectors.

Voir les flashcards →

Approfondir avec la fiche

Consultez la fiche de révision complète sur Fundamentals of Infectious Disease and Antibiotics.

Voir la fiche →

Cours similaires

Crée tes propres QCM

Importe ton cours et l'IA génère des QCM avec corrections en 30 secondes.

Générateur de QCM